靶向 Glypican 3 的 CAR-T 细胞分泌靶向 TROP2 的双特异性 T 细胞衔接器对肺鳞状细胞癌表现出强效疗效
Glypican 3-targeted chimeric antigen receptor T cells secreting TROP2-directed bispecific T cell engagers exhibit potent efficacy against lung squamou
本研究表明,GPC3 CAR-T。
ALL SOURCES
Glypican 3-targeted chimeric antigen receptor T cells secreting TROP2-directed bispecific T cell engagers exhibit potent efficacy against lung squamou
本研究表明,GPC3 CAR-T。
Emerging Targeted and Multimodal Therapeutic Strategies in Breast Cancer: A Comprehensive Review.
这些发现表明,乳腺癌治疗的未来将依赖于针对每个肿瘤和每位患者独特生物学特性设计的个性化、多靶点策略。
Antibody-Mediated Therapy in Gastric Cancer: Past, Present, and Future.
在胃癌治疗中,细胞毒性化疗的疗效有限,这在很大程度上由深刻的分子与生物学异质性所驱动。
Pharmacotherapy for previously treated gastric cancer patients: current options and future developments.
生物标志物驱动的治疗有望在未来成为主流方法。
Advances in adoptive cell therapies in small cell lung cancer.
小细胞肺癌(SCLC)是一种侵袭性肿瘤,以早期转移和治疗耐药为特征,使其成为治疗研究的重点目标。
共 5 条
MEMBER ACCOUNT
登录成功会直接打开下一页。